US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apnimed

27.37

+1.746.79%

Post-market: 27.650.2800+1.02%19:30 EDT

Volume:480.64K

Turnover:13.16M

Market Cap:1.09B

PE:-34.26

High:29.56

Open:26.60

Low:26.01

Close:25.63

52wk High:35.29

52wk Low:16.12

Shares:39.82M

Float Shares:12.00M

Volume Ratio:1.71

T/O Rate:4.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7990

EPS(LYR):-23.7581

ROE:--

ROA:-36.94%

PB:-3.58

PE(LYR):-1.15

Loading ...

Overview Company News Filings

Apnimed, Inc. : Bofa Global Research Initiates Coverage with Buy Rating and Price Objective $41.00

THOMSON REUTERS

Apnimed Initiated at Buy by B of a Securities

LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target

MT Newswires Live

Apnimed initiated with an Overweight at Cantor Fitzgerald

Apnimed initiated with an Outperform at LifeSci Capital

Apnimed initiated with a Buy at BofA

U.S. Research Roundup-Masco, Sherwin-Williams, Vulcan Materials

Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million

Insider Move: Apnimed Director Makes Bold New Investment

Apnimed IPO Raises $220.8 Million at $16 Per Share

Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Apnimed Adopts New IPO-Era Bylaws with Advance Notice Rules for Shareholder Proposals

Apnimed Director Paul J. Sekhri Acquires $200,000 in Common Shares

Apnimed opens at $22.00, IPO priced at $16.00

NASDAQ Trade Halt Volatility Trading Pause at 11:49 Am

Stock Track | Apnimed Soars 37.5% in Intraday Debut After Upsized IPO Priced at Top of Range

Sleep Apnea Pill Developer Apnimed Poised to Jump in Debut After Upsized IPO

Apnimed Upsized IPO Priced at Top of Expectations

NASDAQ Trade Halt Reason not Available at 04:00 Am

Correction: Apnimed Prices $192 Million IPO

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/APMD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","market":"US","secType":"STK","nameCN":"Apnimed","latestPrice":27.37,"timestamp":1787688000000,"preClose":25.63,"halted":0,"volume":480642,"hourTrading":{"tag":"盘后","latestPrice":27.65,"preClose":27.37,"latestTime":"19:30 EDT","volume":4282,"amount":117260.5505,"timestamp":1787700601627,"change":0.28,"changeRate":0.01023,"amplitude":0.01023},"delay":0,"changeRate":0.06788919235271175,"floatShares":12000000,"shares":39823183,"eps":-0.799,"marketStatus":"Not Yet Opened","change":1.74,"latestTime":"08-25 16:00:00 EDT","open":26.6,"high":29.56,"low":26.01,"amount":13155042.727944,"amplitude":0.13851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.799,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"listingDate":1785470400000,"exchange":"NASDAQ","adjPreClose":25.63,"preHourTrading":{"tag":"盘前","latestPrice":27.31,"preClose":25.63,"latestTime":"09:28 EDT","volume":3818,"amount":102162.20053799999,"timestamp":1787664489572,"change":1.68,"changeRate":0.065548,"amplitude":0.073207},"postHourTrading":{"tag":"盘后","latestPrice":27.65,"preClose":27.37,"latestTime":"19:30 EDT","volume":4282,"amount":117260.5505,"timestamp":1787700601627,"change":0.28,"changeRate":0.01023,"amplitude":0.01023},"volumeRatio":1.710168},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","floatShares":12000000,"roa":"-36.94%","roe":"--","lyrEps":-23.758134,"volumeRatio":1.710168,"shares":39823183,"dividePrice":0,"high":29.56,"amplitude":0.13851,"preClose":25.63,"low":26.01,"week52Low":16.12,"pbRate":"-3.58","psRate":"9.07","week52High":35.29,"institutionHeld":0,"latestPrice":27.37,"eps":-0.799,"divideRate":0,"volume":480642,"delay":0,"ttmEps":-0.799,"open":26.6,"prevYearClose":16,"prevWeekClose":28.03,"prevMonthClose":25,"prevQuarterClose":16,"fiveDayClose":31.81,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APMD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APMD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APMD","date":"2026-08-24","current":-34.255319,"percent":0.066667,"low":-12.343549,"twenty":-9.950282,"median":-8.670383,"eighty":-7.986942,"high":-7.725991,"avg":-9.168774,"sd":1.40329,"marketCap":1553511819},"quantilePoints":[{"date":"2026-08-07","current":-8.661063,"twenty":-8.320585,"median":-7.986942,"eighty":-7.766377,"marketCap":1110270342},{"date":"2026-08-14","current":-8.943759,"twenty":-8.664791,"median":-8.256435,"eighty":-7.766377,"marketCap":1146509438},{"date":"2026-08-21","current":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"marketCap":1582331874},{"date":"2026-08-24","current":-12.118728,"twenty":-9.950282,"median":-8.670383,"eighty":-7.986942,"marketCap":1553511819}],"updateTime":1787711747047},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APMD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662173932","title":"Apnimed, Inc. : Bofa Global Research Initiates Coverage with Buy Rating and Price Objective $41.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173932?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:10","pubTimestamp":1787656244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nAZN4TG5UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736246","title":"Apnimed Initiated at Buy by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736246?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:59","pubTimestamp":1787655540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APMD/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273683","title":"LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273683?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:46","pubTimestamp":1787654763,"startTime":"0","endTime":"0","summary":"LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735746","title":"Apnimed initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735746?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:35","pubTimestamp":1787654119,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Apnimed (APMD) with an Overweight rating and $60 price target Published first on TheFly – the ultimate sour...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735898","title":"Apnimed initiated with an Outperform at LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735898?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:20","pubTimestamp":1787653215,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Francois Brisebois initiated coverage of Apnimed (APMD) with an Outperform rating and $50 price target Published first on T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662358957","title":"Apnimed initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662358957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662358957?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:15","pubTimestamp":1787652909,"startTime":"0","endTime":"0","summary":"BofA analyst Jason Gerberry initiated coverage of Apnimed (APMD) with a Buy rating and $41 price target Sole asset Oxnimbi, an oral therapy for obs...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781491","title":"U.S. Research Roundup-Masco, Sherwin-Williams, Vulcan Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781491?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:27","pubTimestamp":1787642845,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan MaterialsAug 25 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Masco","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL8N44M0AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXP","FAC","BKR","DAMD","ALB","AMD","IETC","TEK","FBIN","ACM","INSM","WMS","CSL","MLM","PTF","CLMT","GTLB","APMD","CURB","AMRZ","LEU","VMC","ACAD","JBTM","MRSH","SHW","KRO","GPN","KNF","EMSF","CHYM","AMAT","CLSE","FIS","FLNC","FMC","KDK","SMHX","MAS","AWI","BXP","ANAB","MU","FIVE","LRCX","MRVL","GTEK","DNLI","HON","DT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657679578","title":"Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657679578","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657679578?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:20","pubTimestamp":1785961207,"startTime":"0","endTime":"0","summary":"Morningside Venture Investments reports Apnimed common share acquisition valued at $5 millionMorningside Venture Investments, a 10% owner of Apnimed, converted holdings into 6,840,213 shares of common","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL6MXLgv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656713586","title":"Insider Move: Apnimed Director Makes Bold New Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2656713586","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656713586?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:08","pubTimestamp":1785809300,"startTime":"0","endTime":"0","summary":"New insider activity at Apnimed, Inc. ( ($APMD) ) has taken place on August 3, 2026. Director Paul Sekhri of Apnimed, Inc. has significantly increa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-apnimed-director-makes-bold-new-investment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-apnimed-director-makes-bold-new-investment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656025303","title":"Apnimed IPO Raises $220.8 Million at $16 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2656025303","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656025303?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:46","pubTimestamp":1785790016,"startTime":"0","endTime":"0","summary":"Apnimed IPO raises $220.8 million at $16 per shareApnimed closed an upsized IPO of 13,800,000 common shares at USD 16 per share.Deal size included 1,800,000 shares from the full exercise of the underw","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLtt0cS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BCDF","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4585","SG9999014021.USD","IE00BN0W2T93.GBP","APMD","IE00BKPKM429.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656307836","title":"Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656307836","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656307836?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:35","pubTimestamp":1785789300,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Aug.  03, 2026  (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercializati","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337925/0/en/Apnimed-Announces-Closing-of-Upsized-Initial-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD","IPOS","BK4082","OSA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656090593","title":"Apnimed Adopts New IPO-Era Bylaws with Advance Notice Rules for Shareholder Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2656090593","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656090593?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:03","pubTimestamp":1785787399,"startTime":"0","endTime":"0","summary":"Apnimed adopts new IPO-era bylaws with advance notice rules for shareholder proposalsApnimed adopted second amended and restated bylaws effective Aug. 3, 2026, tied to its initial public offering.The ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3LMVj0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656097513","title":"Apnimed Director Paul J. Sekhri Acquires $200,000 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656097513","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656097513?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787308,"startTime":"0","endTime":"0","summary":"Apnimed director Paul J. Sekhri acquires $200,000 in common sharesApnimed director Paul J. Sekhri reported buying 12,500 common shares at USD 16, lifting his direct holding to 12,500 shares.He also re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL5CHx8G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Apnimed Director Paul J. Sekhri Acquires $200,000 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656398107","title":"Apnimed opens at $22.00, IPO priced at $16.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2656398107","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656398107?lang=en_us&edition=fundamental","pubTime":"2026-08-01 00:15","pubTimestamp":1785514553,"startTime":"0","endTime":"0","summary":"Apnimed (APMD) priced 12M shares at $16.00. The deal size was increased to 12M shares from 10M shares of common stock and priced at the high-end of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-opens-at-22-00-ipo-priced-at-16-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-opens-at-22-00-ipo-priced-at-16-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRHC","BK4127","KCE","IPOS","REDS","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655607223","title":"NASDAQ Trade Halt Volatility Trading Pause at 11:49 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2655607223","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655607223?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:49","pubTimestamp":1785512983,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 11:49 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nAQN2MCM7D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184287020","title":"Stock Track | Apnimed Soars 37.5% in Intraday Debut After Upsized IPO Priced at Top of Range","url":"https://stock-news.laohu8.com/highlight/detail?id=1184287020","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184287020?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:46","pubTimestamp":1785512783,"startTime":"0","endTime":"0","summary":"Shares of Apnimed (APMD) surged 37.5% in intraday trading on Friday, as the clinical-stage biotech made a strong debut on the Nasdaq Global Select Market. The stock opened significantly higher than...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655601183","title":"Sleep Apnea Pill Developer Apnimed Poised to Jump in Debut After Upsized IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2655601183","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655601183?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:32","pubTimestamp":1785511920,"startTime":"0","endTime":"0","summary":"BUZZ-Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO** Late-stage biotech ApnimedAPMD.Oon track to jump in Nasdaq debut on Fri after above-target IPO** APMD shares recently indicated to open at $22 vs $16 offering price** Cambridge, Massachusetts-based firm late Thurs sold 12 mln shares for $192 mln raise** Co had marketed deal size of 10 mln shares at $14-$16** Its sole clinical product candidate, AD109 , is a once-daily pill taken at night to treat obstructive sleep apnea , a condition in which the airway repeatedly collapses during sleep, lowering oxygen levels and disrupting breathing** Morningside, Alpha Wave Ventures and Japanese pharma Shionogi & Co4507.Tare its largest shareholders, per the prospectus** BofA, Evercore, Cantor Fitzgerald and LifeSci Capital joint bookrunners on the IPO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL6N43X12X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","EVR","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655354798","title":"Apnimed Upsized IPO Priced at Top of Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2655354798","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655354798?lang=en_us&edition=fundamental","pubTime":"2026-07-31 17:46","pubTimestamp":1785491160,"startTime":"0","endTime":"0","summary":"Shares of Apnimed are set to make their trading debut Friday after the clinical-stage pharmaceutical company's upsized initial public offering was priced at the high end of expectations, raising $192 million.Apnimed late Thursday said it is selling 12 million shares at $16 each in the IPO, compared with prior plans to offer 10 million shares at between $14 and $16 apiece.Apnimed shares are due to begin trading later Friday on the Nasdaq Global Select Market under the symbol APMD.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REDS","FRHC","BK4127","KCE","APMD","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655949355","title":"NASDAQ Trade Halt Reason not Available at 04:00 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2655949355","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655949355?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:00","pubTimestamp":1785484802,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTREASON NOT AVAILABLE AT 04:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nAQN2MCJ82:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655353955","title":"Correction: Apnimed Prices $192 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2655353955","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655353955?lang=en_us&edition=fundamental","pubTime":"2026-07-31 15:32","pubTimestamp":1785483133,"startTime":"0","endTime":"0","summary":"(Correct company name in the first paragraph)Apnimed has priced its initial public offering of 12 million common shares at $16 per share, the drugmaker said late Thursday.Underwriters have been grante","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KCE","FRHC","APMD","REDS","IPOS","BK4127"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}